Brandywine Global Investment Management LLC grew its holdings in Ingredion Incorporated (NYSE:INGR - Free Report) by 27.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,207 shares of the company's stock after acquiring an additional 18,326 shares during the quarter. Brandywine Global Investment Management LLC owned 0.13% of Ingredion worth $11,656,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in Ingredion by 40.2% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 279 shares of the company's stock valued at $38,000 after purchasing an additional 80 shares during the last quarter. Waverly Advisors LLC grew its position in Ingredion by 3.8% during the 4th quarter. Waverly Advisors LLC now owns 2,303 shares of the company's stock worth $317,000 after acquiring an additional 84 shares during the last quarter. Retirement Guys Formula LLC increased its holdings in Ingredion by 5.7% during the 1st quarter. Retirement Guys Formula LLC now owns 1,566 shares of the company's stock valued at $212,000 after purchasing an additional 84 shares in the last quarter. Wealthspire Advisors LLC raised its position in Ingredion by 5.8% in the 1st quarter. Wealthspire Advisors LLC now owns 1,685 shares of the company's stock valued at $228,000 after purchasing an additional 92 shares during the last quarter. Finally, Hancock Whitney Corp boosted its stake in Ingredion by 1.6% in the fourth quarter. Hancock Whitney Corp now owns 6,854 shares of the company's stock worth $943,000 after purchasing an additional 108 shares in the last quarter. Institutional investors own 85.27% of the company's stock.
Insider Buying and Selling at Ingredion
In related news, CEO James P. Zallie sold 36,287 shares of Ingredion stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $126.52, for a total transaction of $4,591,031.24. Following the completion of the transaction, the chief executive officer owned 50,129 shares in the company, valued at approximately $6,342,321.08. This trade represents a 41.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Larry Fernandes sold 850 shares of the company's stock in a transaction that occurred on Monday, August 4th. The shares were sold at an average price of $128.39, for a total value of $109,131.50. Following the completion of the sale, the senior vice president owned 31,171 shares in the company, valued at $4,002,044.69. This represents a 2.65% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 37,137 shares of company stock worth $4,700,163 over the last ninety days. Insiders own 2.30% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. UBS Group lifted their price target on Ingredion from $149.00 to $151.00 and gave the company a "neutral" rating in a report on Wednesday, July 9th. Wall Street Zen lowered shares of Ingredion from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Ingredion presently has a consensus rating of "Hold" and a consensus price target of $151.40.
Check Out Our Latest Report on Ingredion
Ingredion Stock Up 1.8%
NYSE INGR traded up $2.2650 on Friday, reaching $129.9050. The company had a trading volume of 80,821 shares, compared to its average volume of 521,765. The company's fifty day moving average is $132.76 and its 200-day moving average is $132.69. The firm has a market capitalization of $8.34 billion, a price-to-earnings ratio of 12.67, a price-to-earnings-growth ratio of 1.01 and a beta of 0.71. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.81 and a current ratio of 2.78. Ingredion Incorporated has a 1-year low of $120.51 and a 1-year high of $155.44.
Ingredion (NYSE:INGR - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.78 by $0.09. Ingredion had a net margin of 9.24% and a return on equity of 19.04%. The business had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.89 billion. During the same quarter in the prior year, the company posted $2.87 earnings per share. The firm's revenue was down 2.4% on a year-over-year basis. Ingredion has set its FY 2025 guidance at 11.100-11.600 EPS. On average, research analysts forecast that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.
Ingredion Profile
(
Free Report)
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Featured Articles

Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.